Nihl drug study

Ended Definitive Contract Awarded Aug 15, 2012 Last action Oct 10, 2013

Contract number: N6264512C4037
Awardee: Otologic Pharmaceutics, Inc. UEI MCYMZ54X6TK3
Awarding agency: Bureau of Medicine and Surgery Department of the Navy, Department of Defense
Obligated: $688,600

Award facts

Opportunity: J&A Notice for continued studies into developing a FDA-approved pharmaceutical to treat noise-induced hearing loss (NIHL). Award Notice · Posted Aug 14, 2012

Award notice for continued studies into developing aFDA-approved pharmaceutical to treat noise-induced hearing loss (NIHL). Award Notice · Posted May 22, 2012
Contract value 100% obligated: $688,599.96 Current and potential, with all options
Completion date 100% complete: Aug 14, 2014 Current and potential, with all options
NAICS code: 541711 Research and Development in Biotechnology
PSC: AN42 Health R&D Services; Health Care - Other; Applied Research
Set-aside: No set-aside
Competition: Not Competed · 1 offer Only One Source
Pricing: Firm Fixed Price
Place of performance: Silver Spring, MD 20910, USA

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Other Administrative Action P00003 · Nihl drug study r & d no cost extension MOD	$0	Oct 10, 2013
Other Administrative Action P00002	$0	Jan 30, 2013
Other Administrative Action P00001	-$0	Sep 6, 2012
Original award	$688,600	Aug 13, 2012

N6264512C4037 was awarded to Otologic Pharmaceutics, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on August 15, 2012.

The government has obligated $688,600 on N6264512C4037.

The extent of competition for N6264512C4037 was not competed. The government received 1 offer.

On GovTribe

Try for free Login